These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 11505454

  • 1. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.
    Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Buttò S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, Goebel FD, Hintermaier R, Enders G, Regamey N, Wernli M, Stürzl M, Rezza G, Ensoli B.
    J Med Virol; 2001 Sep; 65(1):123-32. PubMed ID: 11505454
    [Abstract] [Full Text] [Related]

  • 2. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B.
    Virology; 1999 Apr 10; 256(2):381-92. PubMed ID: 10191203
    [Abstract] [Full Text] [Related]

  • 3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA, Pierrotti LC, Sumita LM, Freire WS, Segurado AA, Pannuti CS.
    J Med Virol; 2007 Oct 10; 79(10):1562-8. PubMed ID: 17705173
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
    Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Söderström T, Wadström J, Linde A.
    J Med Virol; 2000 Dec 10; 62(4):498-504. PubMed ID: 11074479
    [Abstract] [Full Text] [Related]

  • 5. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
    Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E.
    Virology; 1998 Mar 30; 243(1):208-17. PubMed ID: 9527930
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC, Carbone PH, de los Santos-Fortuna E, Caterino-de-Araujo A.
    J Med Virol; 2009 Jul 30; 81(7):1292-7. PubMed ID: 19475629
    [Abstract] [Full Text] [Related]

  • 7. Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.
    Chohan BH, Taylor H, Obrigewitch R, Lavreys L, Richardson BA, Mandaliya KN, Bwayo JJ, Kreiss JK, Morrow RA.
    J Clin Virol; 2004 Jun 30; 30(2):137-44. PubMed ID: 15125869
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS.
    Lancet; 1996 Oct 26; 348(9035):1133-8. PubMed ID: 8888167
    [Abstract] [Full Text] [Related]

  • 9. Recombinant ORF66 and ORFK12 antigens for the detection of human herpesvirus 8 antibodies in HIV-positive and -negative patients.
    Yang TC, Chang CP, Lan YC, Liu CL, Shih MC, Wu FY, Lin CW.
    Biotechnol Lett; 2009 May 26; 31(5):629-37. PubMed ID: 19142585
    [Abstract] [Full Text] [Related]

  • 10. Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations.
    Pérez C, Tous M, Benetucci J, Gómez J.
    J Med Virol; 2006 Jun 26; 78(6):806-13. PubMed ID: 16628571
    [Abstract] [Full Text] [Related]

  • 11. The seroprevalence of human herpesvirus 8 infection in the Thai population.
    Ayuthaya PI, Katano H, Inagi R, Auwanit W, Sata T, Kurata T, Yamanishi K.
    Southeast Asian J Trop Med Public Health; 2002 Jun 26; 33(2):297-305. PubMed ID: 12236428
    [Abstract] [Full Text] [Related]

  • 12. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N, Spira T, Lam L, Corchero JL, Luo W.
    J Med Virol; 2004 Oct 26; 74(2):202-6. PubMed ID: 15332267
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary.
    Szalai E, Gerlei Z, Szlávik J, Szládek G, Patel R, Hunyadi J, Gergely L, Juhász A.
    FEMS Immunol Med Microbiol; 2005 Feb 01; 43(2):265-8. PubMed ID: 15681157
    [Abstract] [Full Text] [Related]

  • 14. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
    Caterino-de-Araujo A, Magri MC, Manuel RC.
    J Med Virol; 2010 Sep 01; 82(9):1576-81. PubMed ID: 20648612
    [Abstract] [Full Text] [Related]

  • 15. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.
    Greenblatt RM, Jacobson LP, Levine AM, Melnick S, Anastos K, Cohen M, DeHovitz J, Young MA, Burns D, Miotti P, Koelle DM.
    J Infect Dis; 2001 Apr 01; 183(7):1130-4. PubMed ID: 11237842
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.
    Mbulaiteye SM, Atkinson JO, Whitby D, Wohl DA, Gallant JE, Royal S, Goedert JJ, Rabkin CS.
    J Clin Virol; 2006 Apr 01; 35(4):442-9. PubMed ID: 16414306
    [Abstract] [Full Text] [Related]

  • 17. Comparison of serologic assays for detection of antibodies against human herpesvirus 8.
    Corchero JL, Mar EC, Spira TJ, Pellett PE, Inoue N.
    Clin Diagn Lab Immunol; 2001 Sep 01; 8(5):913-21. PubMed ID: 11527803
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
    Mohanna S, Maco V, Bravo F, Gotuzzo E.
    Int J Infect Dis; 2005 Sep 01; 9(5):239-50. PubMed ID: 16095940
    [Abstract] [Full Text] [Related]

  • 19. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma.
    Tanzi E, Zappa A, Caramaschi F, Amendola A, Lasagna D, Gatti L, Ascoli V, Rezza G, Zanetti AR.
    J Med Virol; 2005 Aug 01; 76(4):571-5. PubMed ID: 15977229
    [Abstract] [Full Text] [Related]

  • 20. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F, Mosam A, Henry LN, Chisholm JV, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.
    AIDS; 2007 Jun 19; 21(10):1245-52. PubMed ID: 17545700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.